1. CFO Bill Nurthen has left RSSS; effective December 10, 2025. 2. Dave Kutil appointed as interim CFO, ensuring continuity. 3. Kutil has 15 years of financial leadership experience. 4. RSSS serves over 70% of top pharmaceutical companies. 5. No immediate operational disruptions expected during leadership transition.
FAQ
Why Neutral?
Leadership changes can create short-term uncertainty but Kutil's internal appointment suggests continuity. Historically, companies with strong interim leaders maintain stability, reducing volatility.
How important is it?
The announcement signals a shift in leadership, impacting investor perception and potential strategy. While important, the internal promotion minimizes disruption, keeping importance moderate.
Why Short Term?
Short-term uncertainty from leadership change may affect stock price, but continuity promises long-term stability. Similar situations usually stabilize within a few months.
Research Solutions, Inc. (NASDAQ: RSSS) Announces CFO Transition
Research Solutions, Inc. (NASDAQ: RSSS), a leader in AI-powered research workflow platforms, has announced a significant executive transition. Effective December 10, 2025, Bill Nurthen has left his position as Chief Financial Officer and Secretary of the Company to pursue new opportunities.
New Interim CFO Appointed
In light of Mr. Nurthen's departure, Research Solutions has appointed Dave Kutil, the Company's Controller, as the interim Chief Financial Officer and Secretary. Mr. Kutil has been with Research Solutions since 2023 and brings over 15 years of financial leadership experience to his new role. Prior to joining, he held the position of Controller for the North American subsidiary of Lesaffre, a major global consumer goods firm, and served as the Director of Accounting at Badger Meter.
Leadership Insights on the Transition
Roy W. Olivier, Chairman and Chief Executive Officer of Research Solutions, expressed gratitude to Mr. Nurthen for his four years of service. He stated, "I would like to thank Bill for his contributions to the Company over the past four years and welcome Dave into this role as interim CFO and Secretary." Olivier further emphasized that Kutil shares the Company's long-term strategic financial vision, having worked closely with Nurthen since his arrival. He expressed confidence in Kutil’s ability to execute the responsibilities of the CFO position without disruption to ongoing operations.
About Research Solutions, Inc.
Founded in 2006 as Reprints Desk, Research Solutions, Inc. (NASDAQ: RSSS) is renowned for its cloud-based technologies that facilitate the efficient acquisition and management of intellectual property. The Company’s flagship product, Article Galaxy, is widely utilized by over 70% of leading pharmaceutical companies, prestigious academic institutions, and emerging businesses. Research Solutions is committed to providing clients with seamless access to the latest scientific research and data, supported by round-the-clock customer service.
- Founded: 2006
- Previous Name: Reprints Desk
- Market Position: Leading AI-powered research workflow platform
- Client Base: Over 70% of top pharmaceutical firms and major universities
For further details, visit www.researchsolutions.com.